Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib

Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib

Drug-induced thrombotic microangiopathies (DTMAs) are increasingly being recognized as an important category of thrombotic microangiopathies (TMAs). Cancer therapeutic agents including proteasome inhibitors (PIs) are among the most common medications reported to cause DTMA. PIs could cause DTMA eith...

Full description

Bibliographic Details
Main Authors: Suheil Albert Atallah-Yunes, Myat Han Soe
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2018/7063145

Similar Items

Similar Items